Valuation: OssDsign AB (publ)

Market Cap 459M 48.26M 41.82M 39.15M 35.73M 67.23M 4.6B 68.36M 180M 2.3B 181M 177M 7.69B P/E 2026 *
-8.89x
P/E 2027 * -12.7x
Enterprise Value 342M 35.96M 31.16M 29.18M 26.62M 50.1M 3.43B 50.94M 134M 1.72B 135M 132M 5.73B EV / Sales 2026 *
2.04x
EV / Sales 2027 * 1.66x
Free-Float
67.17%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 01/01/2026
Director of Finance/CFO 63 01/01/2020
Chief Tech/Sci/R&D Officer 47 01/01/2022
Director TitleAgeSince
Chairman 66 20/04/2016
Director/Board Member 60 01/01/2022
Director/Board Member 61 25/06/2024
Change 5-day change 1-year change 3-year change Capi.($)
-36.11%-.--% - - 48.38M
+0.52%+3.32%-7.85%+23.04% 133B
+0.23%-1.25%-17.50%-1.03% 12.57B
+0.42%+6.92%+109.53%+145.10% 10.7B
-1.85%-2.19%-43.54%-67.82% 4.72B
+0.52%+4.05%-24.37%+38.33% 2.68B
+0.08%-7.12%-25.19%-75.47% 1.73B
-0.86%+0.43%-15.04%-13.17% 1.7B
-0.33%-2.34%-33.53%-31.81% 1.67B
Average -4.19%+210.90%-7.19%+2.15% 21.05B
Weighted average by Cap. +0.34%+361.62%-2.88%+24.77%

Financials

2026 *2027 *
Net sales 168M 17.61M 15.26M 14.29M 13.04M 24.53M 1.68B 24.95M 65.64M 841M 66.13M 64.69M 2.8B 238M 25.05M 21.71M 20.33M 18.55M 34.9M 2.39B 35.49M 93.38M 1.2B 94.07M 92.02M 3.99B
Net income -51.27M -5.39M -4.67M -4.37M -3.99M -7.51M -514M -7.63M -20.09M -257M -20.24M -19.79M -858M -35.73M -3.76M -3.26M -3.05M -2.78M -5.23M -358M -5.32M -14M -179M -14.1M -13.8M -598M
Net Debt -117M -12.3M -10.66M -9.98M -9.1M -17.13M -1.17B -17.42M -45.84M -587M -46.18M -45.17M -1.96B -63M -6.62M -5.74M -5.37M -4.9M -9.23M -632M -9.38M -24.68M -316M -24.87M -24.32M -1.05B
Logo OssDsign AB (publ)
OssDsign AB, formerly known as Oss-Q AB is a Sweden-based orthopedic medical device company. It aims at developing implantable products that respond to clinical challenges, with focus on bone healing. Its primary focus is skull surgery. The Company uses design solutions, material compositions and manufacturing processes mainly based on proprietary bioceramic technologies. The bioceramics it uses integrate with tissues and support bone ingrowth. OssDsign AB's main product is Craniomosaic, an implant for the repair of skull defects (cranioplasty). Along with it, the Company develops bioceramic implants for facial bone augmentation. The Company's customers include neurosurgeons, craniofacial and maxillofacial surgeons.
Employees
35
Trader
Investor
-
Global
-
Quality
ESG MSCI
-